LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas

Condition:   Recurrent Glioblastoma Interventions:   Procedure: Laser interstitial thermal therapy;   Drug: Temozolomide Sponsor:   Beijing Tiantan Hospital Active, not recruiting

Source: ClinicalTrials.gov - December 23, 2022 Category: Research Source Type: clinical trials